NOC
41
9
SYF
86
-6
EIX
70
3
KMI
69
-2
F
56
-3
DFS
64
2
JBHT
56
-3
HRL
35
-3
HST
39
-3
HBI
58
3
BBY
52
6
AA
56
15
NI
72
4
PFE
14
-7
SPG
60
2
NOV
52
-5
VRSK
68
-12
FMC
23
-3
HSIC
45
5
ETR
65
2
NOC
41
9
SYF
86
-6
EIX
70
3
KMI
69
-2
F
56
-3
DFS
64
2
JBHT
56
-3
HRL
35
-3
HST
39
-3
HBI
58
3
BBY
52
6
AA
56
15
NI
72
4
PFE
14
-7
SPG
60
2
NOV
52
-5
VRSK
68
-12
FMC
23
-3
HSIC
45
5
ETR
65
2
Financhill
Back

FolioBeyond Altand Int Rt Hdg ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
37

RISR
FolioBeyond Altand Int Rt Hdg ETF

Last Price:
35.85
Seasonality Move:
5.38%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
37
FolioBeyond Altand Int Rt Hdg ETF (RISR) is a Sell

Is FolioBeyond Altand Int Rt Hdg ETF a Buy, Sell or Hold?

  • The current FolioBeyond Altand Int Rt Hdg ETF [RISR] share price is $35.85. The Score for RISR is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • RISR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RISR Stock Price Chart

What is FolioBeyond Altand Int Rt Hdg ETF's stock price today?

  • The FolioBeyond Altand Int Rt Hdg ETF share price today is $35.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RISR is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

RISR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.3 Buy
Relative Strength Index (14 RSI): 63.07 Buy
Chaikin Money Flow: -2213 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.1 - 35.8) Buy
Bollinger Bands (100): (33.95 - 35.25) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

RISR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.71 Buy
20-day SMA: 35.61 Buy
50-day SMA: 34.71 Buy
200-day SMA: 34.32 Buy
8-day EMA: 35.76 Buy
20-day EMA: 35.51 Buy
50-day EMA: 35.03 Buy
200-day EMA: 34.29 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

FolioBeyond Altand Int Rt Hdg ETF Earnings Growth & RISR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

FolioBeyond Altand Int Rt Hdg ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):